Imoxicate 40 mg/4 mg spot-on solution for small cats and ferrets
Imoxicate 40 mg/4 mg spot-on solution for small cats and ferrets
Authorised
This information is not available for this product.
Product identification
Medicine name:
Imoxicate 40 mg/4 mg spot-on solution for small cats and ferrets
Imoxicate 40 mg/4 mg spot-on solution for small cats and ferrets
Active substance:
This information is not available for this product.
Target species:
-
Cat
-
Ferret
Route of administration:
-
Spot-on use
Product details
Active substance and strength:
This information is not available for this product.
Pharmaceutical form:
-
Spot-on solution
Withdrawal period by route of administration:
-
Spot-on use
- Cat
- Ferret
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP54AB52
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- A white polypropylene (PP) unit dose pipette with a closure with a spike composed of high density polyethylene (HDPE) orpolyoxymethylene (POM) or polypropylene (PP) packed into a laminated triplex bag composed of polyester (PETP), aluminium(Al) and low density polyetylene (LDPE).Cardboard box containing 1 pipettes.
- A white polypropylene (PP) unit dose pipette with a closure with a spike composed of high density polyethylene (HDPE) orpolyoxymethylene (POM) or polypropylene (PP) packed into a laminated triplex bag composed of polyester (PETP), aluminium(Al) and low density polyetylene (LDPE).Cardboard box containing 3 pipettes.
- A white polypropylene (PP) unit dose pipette with a closure with a spike composed of high density polyethylene (HDPE) orpolyoxymethylene (POM) or polypropylene (PP) packed into a laminated triplex bag composed of polyester (PETP), aluminium(Al) and low density polyetylene (LDPE).Cardboard box containing 4 pipettes.
- A white polypropylene (PP) unit dose pipette with a closure with a spike composed of high density polyethylene (HDPE) orpolyoxymethylene (POM) or polypropylene (PP) packed into a laminated triplex bag composed of polyester (PETP), aluminium(Al) and low density polyetylene (LDPE).Cardboard box containing 6 pipettes.
- A white polypropylene (PP) unit dose pipette with a closure with a spike composed of high density polyethylene (HDPE) orpolyoxymethylene (POM) or polypropylene (PP) packed into a laminated triplex bag composed of polyester (PETP), aluminium(Al) and low density polyetylene (LDPE).Cardboard box containing 24 pipettes.
- A white polypropylene (PP) unit dose pipette with a closure with a spike composed of high density polyethylene (HDPE) orpolyoxymethylene (POM) or polypropylene (PP) packed into a laminated triplex bag composed of polyester (PETP), aluminium(Al) and low density polyetylene (LDPE).Cardboard box containing 48 pipettes.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
- Tad Pharma GmbH
- Krka d.d. Novo Mesto
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10774/065/001
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0565/001
Concerned member states:
-
Germany
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 28/01/2022
How useful was this page?: